Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Inhibitors of COX-1/COX-2 from Roche

Jan. 22, 1998

Hydroxamic acid-based inhibitors of TNF and/or MMPs under study at Zeneca

Jan. 22, 1998

Innovative Therapies for Rheumatoid Arthritis

Jan. 22, 1998

Preclinical efficacy results reported for Maruho's NSAID

Jan. 20, 1998

Thienopyridine derivatives for arthritis, osteoporosis from Takeda

Jan. 19, 1998

Prodrugs of COX-2 inhibitors prepared at Searle

Jan. 15, 1998

Pivotal trial of PROSORBA column in RA stopped early due to favorable results

Jan. 15, 1998

Pharmacia & Upjohn prepares MMP inhibitors

Jan. 13, 1998

Selective COX-2 inhibitors under study at Merck Frosst

Jan. 13, 1998

Effects of neutrophil elastase inhibitor MDL-101146 in two arthritis models

Jan. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...